Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Period	Milestone	Group	Participants
Overall Study	STARTED	Cohort A Pembrolizumab/Vibostolimab Coformulation	42
Overall Study	STARTED	Cohort B Pembrolizumab/Vibostolimab Coformulation	42
Overall Study	STARTED	Cohort C Pembrolizumab/Vibostolimab Coformulation	20
Overall Study	STARTED	Cohort D Pembrolizumab/Vibostolimab Coformulation	30
Overall Study	STARTED	Cohort E Pembrolizumab/Vibostolimab Coformulation	25
Overall Study	STARTED	Cohort F Pembrolizumab/Vibostolimab Coformulation	33
Overall Study	Treated	Cohort A Pembrolizumab/Vibostolimab Coformulation	42
Overall Study	Treated	Cohort B Pembrolizumab/Vibostolimab Coformulation	42
Overall Study	Treated	Cohort C Pembrolizumab/Vibostolimab Coformulation	20
Overall Study	Treated	Cohort D Pembrolizumab/Vibostolimab Coformulation	30
Overall Study	Treated	Cohort E Pembrolizumab/Vibostolimab Coformulation	25
Overall Study	Treated	Cohort F Pembrolizumab/Vibostolimab Coformulation	32
Overall Study	COMPLETED	Cohort A Pembrolizumab/Vibostolimab Coformulation	0
Overall Study	COMPLETED	Cohort B Pembrolizumab/Vibostolimab Coformulation	0
Overall Study	COMPLETED	Cohort C Pembrolizumab/Vibostolimab Coformulation	0
Overall Study	COMPLETED	Cohort D Pembrolizumab/Vibostolimab Coformulation	0
Overall Study	COMPLETED	Cohort E Pembrolizumab/Vibostolimab Coformulation	0
Overall Study	COMPLETED	Cohort F Pembrolizumab/Vibostolimab Coformulation	0
Overall Study	NOT COMPLETED	Cohort A Pembrolizumab/Vibostolimab Coformulation	42
Overall Study	NOT COMPLETED	Cohort B Pembrolizumab/Vibostolimab Coformulation	42

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05005442/flow